Aida Saliby, M.D.

Bradley B. Pua, M.D.Chief, Division of Interventional Radiology Director, Lung Cancer Screening Program Director, Radiology Consultation ServicesDr. Bradley Pua is a nationally recognized leader in Interventional Radiology, known for advancing multidisciplinary care, early cancer detection, and procedural innovation. He earned his B.S. in Chemistry from New York University (NYU) and completed his M.D. at NYU School of Medicine. After three years of surgical residency at NYU Medical Center, he trained in Interventional Radiology through a fellowship at NewYork-Presbyterian/Weill Cornell and Memorial Sloan Kettering Cancer Center. He completed his diagnostic radiology residency at Cornell, serving as Chief Resident.Dr. Pua’s clinical practice includes a wide range of image-guided therapies such as embolization, stent placement, tumor ablation, biopsy, and vascular access. His focus areas include pediatric interventions and minimally invasive cancer therapy, with particular expertise in thoracic tumors.He co-founded a multidisciplinary vascular anomalies team that provides coordinated, longitudinal care for patients with hemangiomas, arteriovenous malformations, venous anomalies, and lymphatic disorders.As Director of the Lung Cancer Screening Program, Dr. Pua has streamlined diagnostic and therapeutic pathways for pulmonary nodules, accelerating access to curative treatment. He leads and collaborates on multiple clinical trials focused on minimally invasive lung tumor treatment, utilizing advanced techniques such as radiofrequency, microwave, cryoablation, and pulsed electric field ablation.A champion of emerging technology, Dr. Pua integrates augmented reality (AR) solutions into procedural planning and image-guided interventions. His work explores how AR overlays can enhance precision, safety, and outcomes across interventional oncology and complex vascular treatments.https://www.cbsnews.com/newyork/news/how-2-new-yorkers-are-tipping-the-odds-of-lung-cancer-survival/

John Ng, M.D. is a Board Certified Radiation Oncologist and Assistant Professor of Radiation Oncology at Weill Cornell Medical College/New York Presbyterian Hospital. As a native New Yorker, he received his undergraduate degree in Physics at Columbia University. He went to medical school at Harvard and also received a Master of Science degree in Biophysics from Harvard University. He received his M.D. degree from Harvard Medical School, jointly with the Massachusetts Institute of Technology, as part of the Health Sciences and Technology (HST) program. He returned to New York City and the Columbia University Medical Center for his residency training in Radiation Oncology, where he also served as a chief resident. He joined the Weill Cornell Medical Center as faculty, where he serves as attending physician for Breast Oncology and for Gastrointestinal Oncology. His most recent awards include the Faculty Educator of the Year Award from the Weill Cornell New York-Presbyterian Residency Program, a RSNA Roentgen Research Award, an ASCO Research Travel Award, and a NCCN Travel Grant.Dr. Ng was recently appointed the Chair of the Radiation Oncology Section of New York Roentgen Society, the only scientific group that congregates radiation oncologists in the New York Metropolitan area and is comprised of leaders in the fields of diagnostic radiology and radiation oncology. He also currently serves as a Program Committee member for the American Association for Cancer Research (AACR), serves on the Economics Committee of the American College of Radiation Oncology (ACRO), and is an active Program Committee member of the New York Metropolitan Breast Cancer Group.Areas of Specialization:Breast Cancer, Gastrointestinal Cancers, Breast Intraoperative Radiotherapy, Breast Balloon Brachytherapy, Pancreatic Cancer, Sarcoma, Stereotactic Body Radiotherapy (SBRT).Research:Dr. Ng’s research is focused on developing novel radiation techniques that can reduce treatment side effects and improve outcomes. One area of particular focus is developing partial breast radiotherapy techniques to treat less breast tissue with less radiation to reduce side effects and to shorten treatment times.Another research interest is advancing radiotherapy technologies to treat pancreatic cancer. He is currently writing a textbook review on Gastrointestinal and Hepatobiliary Radiation Therapy and working on a review on minimizing malignancy risks after radiation therapy.He is also actively involved in the development of new drugs and agents to use with radiotherapy to improve cure rates for breast cancer and gastrointestinal cancers. Presently, his group is collaborating with others in developing skin products to decrease skin side effects from breast radiotherapy.

David W. Trost, MD, is Associate Professor of Clinical Radiology and Director of Interventional Radiology at the Weill Medical College of Cornell University in New York. He also serves as Associate Attending Radiologist at the New York Presbyterian Hospital. Dr. Trost received his medical degree from Georgetown University School of Medicine in Washington, DC. His postgraduate training included a residency in Diagnostic Radiology at St Vincent's Hospital Medical Center in New York and a fellowship in Cardiovascular and Interventional Radiology at New York Hospital Cornell Medical Center.Dr. Trost currently serves as reviewer for Radiology, Transplantation and the Journal of Vascular and Interventional Radiology. In addition he serves as examiner for the American Board of Radiology.Dr. Trost is a member of several professional organizations, The Radiological Society of North America, the Society of Interventional Radiology, and the Cardiovascular and Interventional Radiological Society of Europe.Top Procedures:1. Minimally invasive treatment of malignant and benign tumors of the liver, kidney and bone 2. Inferior vena caval filters. 3. Venous access 4. Pediatric interventions